Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

• Last SEC data release: 2025-03-31
• Last 15 days FTD volume: A$4.1 M
• Last 3 months FTD volume: A$9.92 M
• Last year FTD volume: A$9.92 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Novavax NVAX	A$7.51 M	A$0.11 B	🇺🇸 USA
BioMarin Pharmaceutical BMRN	A$0.73 M	A$23.81 M	🇺🇸 USA
Neurocrine Biosciences NBIX	A$16.56 M	A$25.57 M	🇺🇸 USA
General Electric GE	A$0.30 B	A$0.95 B	🇺🇸 USA
Thermo Fisher Scientific TMO	A$17.07 M	A$0.11 B	🇺🇸 USA
Bristol-Myers Squibb BMY	A$30 M	A$0.30 B	🇺🇸 USA
Pfizer PFE	A$33.22 M	A$0.35 B	🇺🇸 USA
Bio-Techne TECH	A$0.84 M	A$18.2 M	🇺🇸 USA
Sangamo Therapeutics SGMO	A$0.45 M	A$6.55 M	🇺🇸 USA
Charles River Laboratories CRL	A$41.63 M	A$85.1 M	🇺🇸 USA